Haemolytic disease of the newborn: ABO and Rh incompatibility
- Topic
When a mother's antibodies attack her baby's red cells, the baby becomes jaundiced and anaemic. ABO is common and mild; Rh is rarer and can be severe.
What it is
Haemolytic disease of the fetus and newborn happens when maternal IgG antibodies cross the placenta and destroy fetal red cells carrying an antigen the mother lacks. ABO incompatibility (usually a group O mother with a group A or B baby) is the commonest cause: it is usually much milder than Rh disease, causing early jaundice and mild anaemia. Rh (D) disease needs prior sensitisation (a previous pregnancy, miscarriage, bleeding or transfusion), so it typically affects later pregnancies and can cause severe fetal anaemia, hydrops and stillbirth. Anti-D immunoglobulin given to Rh-negative mothers has made it rare.
Key facts
- Jaundice in the first 24 hours of life is pathological; haemolysis is a leading cause.
- ABO: group O mother, A or B baby; the most common immune cause and usually mild.
- Rh: Rh-negative mother sensitised earlier, Rh-positive baby, later pregnancies, can cause hydrops fetalis.
- Anti-D immunoglobulin is given to unsensitised Rh-negative mothers in pregnancy and after delivery of an Rh-positive baby and after sensitising events.
- Treatment is phototherapy for rising bilirubin; exchange transfusion or IVIG for severe cases per specialist.
Step by step
- Know the mother's blood group and antibody screen; test the baby's group and direct antiglobulin test when indicated.
- Measure bilirubin in any baby jaundiced in the first 24 hours.
- Plot bilirubin on an hour-specific nomogram; check haemoglobin and reticulocytes.
- Start phototherapy at the thresholds for age and risk.
- Severe or rapidly rising bilirubin or anaemia: exchange transfusion or IVIG in a neonatal unit.
- Follow up for late anaemia in the following weeks.
ABO versus Rh haemolytic disease
| Feature | ABO | Rh (D) |
|---|---|---|
| Mother | Group O | Rh-negative, sensitised |
| How common | Most common immune cause | Rarer since anti-D prophylaxis |
| Severity | Usually mild: jaundice, mild anaemia | Can be severe: hydrops, stillbirth |
| Prevention | None | Anti-D immunoglobulin |
In clinical practice
- A baby jaundiced on the first day should not be sent home without a bilirubin level.
- Late anaemia can appear weeks after birth in babies with haemolytic disease.
Next step / Initial management
- Maternal and infant blood groups, direct antiglobulin test, bilirubin (total and direct), haemoglobin, reticulocytes, smear.
- Serial bilirubin plotted on an hour-specific chart.
- Rapidly rising bilirubin, severe anaemia or hydrops: urgent referral to a neonatal unit able to perform exchange transfusion.
Common traps
- ABO haemolytic disease is as dangerous as Rh disease: ABO disease is usually much milder.
- Phototherapy is the only treatment for isoimmune haemolysis: IVIG or exchange transfusion is used when bilirubin nears the exchange threshold.
- Jaundice on day one is physiological: jaundice in the first 24 hours is pathological until proven otherwise.
- Anti-D is only needed after delivery: it is also given in pregnancy and after bleeding, miscarriage or procedures.
Test yourself
Think of the answer, then tap the question to see it.
A group O mother's baby (group A) is jaundiced at 18 hours and the mother's Rh status is positive. Most likely cause?
ABO haemolytic disease of the newborn.
Why does Rh disease usually spare the first pregnancy?
The mother must first be sensitised to the D antigen; the strong IgG response affects later Rh-positive babies.
What prevents Rh haemolytic disease?
Anti-D immunoglobulin given to unsensitised Rh-negative mothers in pregnancy, after delivery of an Rh-positive baby and after sensitising events.
Elsewhere in DurgiPedia
Connections
Educational content; it does not replace assessment by a doctor and is not a clinical instruction. If a child has difficulty breathing, cannot drink, vomits everything, has a seizure, is very drowsy, or is a baby under three months with fever, go to an emergency department at once.
Sources: Haemolytic disease of the fetus and newborn (HDFN) (NHS (UK National Health Service), 2026); Comparison of demographic characteristics and haematological parameters in newborns with and without haemolytic disease due to ABO incompatibility (BMC Pediatrics (open access, Europe PMC), 2025); The timing of using IVIG for neonatal ABO hemolytic disease (BMC Pediatrics (open access, Europe PMC), 2025).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
